Peter E. Heding

486 total citations
9 papers, 355 citations indexed

About

Peter E. Heding is a scholar working on Surgery, Molecular Biology and Genetics. According to data from OpenAlex, Peter E. Heding has authored 9 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 4 papers in Molecular Biology and 4 papers in Genetics. Recurrent topics in Peter E. Heding's work include Diabetes and associated disorders (4 papers), Pancreatic function and diabetes (4 papers) and Cytokine Signaling Pathways and Interactions (3 papers). Peter E. Heding is often cited by papers focused on Diabetes and associated disorders (4 papers), Pancreatic function and diabetes (4 papers) and Cytokine Signaling Pathways and Interactions (3 papers). Peter E. Heding collaborates with scholars based in Denmark, Sweden and United States. Peter E. Heding's co-authors include Thomas Mandrup‐Poulsen, Nils Billestrup, Sif G. Rønn, Philip Cohen, Allan E. Karlsen, Flemming Pociot, Thomas Sparre, Martin R. Larsen, Christine Bruun and Ole N. Jensen and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Diabetologia and Molecular Endocrinology.

In The Last Decade

Peter E. Heding

9 papers receiving 349 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter E. Heding Denmark	8	158	122	109	84	84	9	355
Karen Lindberg Denmark	5	135 0.9×	167 1.4×	210 1.9×	110 1.3×	128 1.5×	5	452
Xue Hou China	11	52 0.3×	202 1.7×	105 1.0×	110 1.3×	63 0.8×	23	431
Jia‐Hao Xiao United States	8	59 0.4×	358 2.9×	133 1.2×	68 0.8×	131 1.6×	8	548
Laurence Christa France	11	53 0.3×	109 0.9×	85 0.8×	163 1.9×	50 0.6×	16	351
Wei Ping Li United States	6	66 0.4×	256 2.1×	70 0.6×	227 2.7×	45 0.5×	8	492
Laima Taraseviciene United States	4	114 0.7×	229 1.9×	55 0.5×	32 0.4×	123 1.5×	4	452
Mei-Shiue Kuo France	8	89 0.6×	371 3.0×	83 0.8×	64 0.8×	59 0.7×	11	483
Hsin-Hsiung Tai United States	8	60 0.4×	164 1.3×	44 0.4×	27 0.3×	71 0.8×	10	359
Z S Ji United States	7	63 0.4×	170 1.4×	22 0.2×	151 1.8×	66 0.8×	9	423
Yoshiko Onozawa Japan	7	78 0.5×	190 1.6×	61 0.6×	48 0.6×	17 0.2×	7	333

Countries citing papers authored by Peter E. Heding

Since Specialization

Citations

This map shows the geographic impact of Peter E. Heding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter E. Heding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter E. Heding more than expected).

Fields of papers citing papers by Peter E. Heding

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter E. Heding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter E. Heding. The network helps show where Peter E. Heding may publish in the future.

Co-authorship network of co-authors of Peter E. Heding

This figure shows the co-authorship network connecting the top 25 collaborators of Peter E. Heding. A scholar is included among the top collaborators of Peter E. Heding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter E. Heding. Peter E. Heding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Bruun, Christine, Peter E. Heding, Sif G. Rønn, et al.. (2009). Suppressor of cytokine signalling-3 inhibits tumor necrosis factor-alpha induced apoptosis and signalling in beta cells. Molecular and Cellular Endocrinology. 311(1-2). 32–38. 32 indexed citations

Rønn, Sif G., Christine Bruun, Peter E. Heding, et al.. (2008). Suppressor of cytokine signalling-3 expression inhibits cytokine-mediated destruction of primary mouse and rat pancreatic islets and delays allograft rejection. Diabetologia. 51(10). 1873–1882. 30 indexed citations

Karlsen, Allan E., Zenia M. Størling, Thomas Sparre, et al.. (2006). Immune-mediated β-cell destruction in vitro and in vivo—A pivotal role for galectin-3. Biochemical and Biophysical Research Communications. 344(1). 406–415. 34 indexed citations

Størling, Joachim, Peter E. Heding, Vladimir Berezin, et al.. (2006). IL-1β-induced pro-apoptotic signalling is facilitated by NCAM/FGF receptor signalling and inhibited by the C3d ligand in the INS-1E rat beta cell line. Diabetologia. 49(8). 1864–1875. 12 indexed citations

Rønn, Sif G., et al.. (2006). Suppressor of Cytokine Signaling-3 Inhibits Interleukin-1 Signaling by Targeting the TRAF-6/TAK1 Complex. Molecular Endocrinology. 20(7). 1587–1596. 138 indexed citations

Sparre, Thomas, Martin R. Larsen, Peter E. Heding, et al.. (2005). Unraveling the Pathogenesis of Type 1 Diabetes with Proteomics: Present And Future Directions. Molecular & Cellular Proteomics. 4(4). 441–457. 45 indexed citations

Sparre, Thomas, Martin R. Larsen, Peter E. Heding, et al.. (2005). Unraveling the Pathogenesis of Type 1 Diabetes with Proteomics. 1 indexed citations

Karlsen, Allan E., Peter E. Heding, Martine I. Darville, et al.. (2004). Suppressor of cytokine signalling (SOCS)-3 protects beta cells against IL-1?-mediated toxicity through inhibition of multiple nuclear factor-?B-regulated proapoptotic pathways. Diabetologia. 47(11). 1998–2011. 48 indexed citations

Bergholdt, Regine, Peter E. Heding, Karin Kramer Nielsen, et al.. (2004). Type 1 database mellitus: an inflammatory disease of the islet.. PubMed. 552. 129–53. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact